<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">2244</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>VENDOR DEVELOPMENT IN PHARMA INDUSTRY&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Janodia</surname><given-names>Manthan D</given-names></name></contrib><contrib contrib-type="author"><name><surname>Saxena</surname><given-names>Kunal</given-names></name></contrib><contrib contrib-type="author"><name><surname>D.Sreedhar</surname><given-names/></name></contrib><contrib contrib-type="author"><name><surname>Ligade</surname><given-names>Virendra S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pise</surname><given-names>Ajay</given-names></name></contrib><contrib contrib-type="author"><name><surname>N.</surname><given-names>Udupa</given-names></name></contrib></contrib-group><volume/><issue/><fpage>20</fpage><lpage>29</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Vendor development is essential for buying of material in right quantity, of right quality, at right price from a right source, at right time and place. Thus, source selection begins after the user department forwards material requisition form to purchase department. The purchase department thus, calls&#13;
quotations, invites tenders, receives and processes them. The comparative statements, on the basis of offers made must exhibit in addition to price differentials, a brief history of tenders in respect of their quality standards dependability and performance reliability. After critical examination of all the aspects based on information supplied by them, a particular vendor is selected who can establish suitability criterion in most&#13;
effective manner. On asking, selected vendor generally supply __ampersandsignbdquo;initial sample?. If approved, this would then be followed by __ampersandsignbdquo;initial supply?. The evaluation of initial supply results should be supplemented by on-the-spot study team visits at the vendor?s plant consisting of production engineers, quality controllers, cost-accountants and finance expert. The team should make a detailed study of processes, organization and other allied matters necessary for vendor evaluation. This composite scheme would then form the basis for vendor selection rather than by results of a single sample as practiced in many organizations. On the basis of&#13;
this study, bulk supply orders should follow.&#13;
</p></abstract><kwd-group><kwd/></kwd-group></article-meta></front></article>
